Related Experiment Video
Updated: Mar 6, 2026
04:23
Application of Hemostatic Devices in Laparoscopic Hepatectomy
Published on: April 19, 2022
2.9K
Hemostatic issues in pregnancy-induced liver disease
1Surgical Research Laboratory, Department of Surgery, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Thrombosis Research
|March 7, 2017
Summary
Liver diseases significantly alter the hemostatic system, leading to a balance between clotting and bleeding factors. Pregnancy-related liver conditions like acute fatty liver and HELLP syndrome present unique hemostatic challenges.
Area of Science:
- Hematology
- Hepatology
- Obstetrics
Background:
- Liver diseases profoundly impact the hemostatic system, affecting clotting and bleeding factors.
- Chronic and acute liver diseases often result in a balanced hemostatic state due to simultaneous declines in pro- and anti-hemostatic drivers.
- Pregnancy-associated liver diseases represent a unique category with distinct hemostatic alterations.
Purpose of the Study:
- To summarize the hemostatic changes associated with various liver diseases, with a focus on pregnancy-related conditions.
- To differentiate the hemostatic profiles in acute fatty liver of pregnancy, preeclampsia, HELLP syndrome, and intrahepatic cholestasis of pregnancy.
Main Methods:
- Review of existing literature on hemostatic system alterations in liver diseases.
- Analysis of hemostatic profiles in specific pregnancy-related liver conditions.
- Comparison of hemostatic changes across different liver disease categories.
Main Results:
- Liver diseases commonly cause thrombocytopenia, decreased pro- and anticoagulant levels, and altered fibrinolysis.
- Acute fatty liver of pregnancy and HELLP syndrome exhibit significant hemostatic changes, including thrombocytopenia and potential disseminated intravascular coagulation.
- Intrahepatic cholestasis of pregnancy shows no clinically significant hemostatic alterations despite biochemical liver injury.
Conclusions:
- The hemostatic system in liver disease is complex, often achieving a relative balance.
- Pregnancy-associated liver diseases, particularly acute fatty liver and HELLP syndrome, pose significant risks for bleeding due to profound hemostatic derangements.
- Clinical vigilance for hemostatic complications is crucial in patients with liver disease, especially during pregnancy.
Related Concept Videos
01:24Disorders of Hemostasis
2.5K
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
2.5K
01:26Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
304
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
304
01:30Venous Thrombosis IV: Nursing Management
333
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
333
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
2.2K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.2K
01:22Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
244
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
244
01:20Extrinsic and Intrinsic Pathways of Hemostasis
14.3K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
14.3K